You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. Cymabay Therapeutics Inc
  2. Company Profile
person reading

About Cymabay Therapeutics Inc - Company Information, Overview, History and Profile

What does Cymabay Therapeutics Inc do?

CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and MBX-2982 (a GPR119 agonist).

Cymabay Therapeutics Inc Management structure

All Gross Remunerations are in USD
Mr. Harish Shantharam
Principal Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Cymabay Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Mr. Kurt von Emster, C.F.A.
Independent Director
-
2023
Gross Remuneration
Year
Mr. Thomas G. Wiggans
Independent Director
-
2023
Gross Remuneration
Year
Ms. Caroline M. Loewy
Independent Director
-
2023
Gross Remuneration
Year
Mr. Sujal Shah
Director, President and Chief Executive Officer
-
2023
Gross Remuneration
Year
Dr. Eric Lefebvre, M.D.
Independent Director
-
2023
Gross Remuneration
Year
Dr. Robert J. Wills, PhD
Chairman of the Board
-
2023
Gross Remuneration
Year